What to Expect from a Personalized Weight Loss Plan

Ashley Harwyn, PA-C, ABAAHP  |  Published August 4, 2025  |  Last updated October 6, 2026  |  19 min read

Intake, labs, body measurements, a written plan, and a follow-up schedule: each stage of a supervised weight loss program, and where medication fits by the guidelines.

This guide walks through each stage in the order you will meet it, with what national guidelines and FDA drug labels say should happen at that step. If you are still trying to work out why your weight is stuck in the first place, our post on the medical reasons weight loss stalls covers the causes. This post picks up where that one ends: what the program itself looks like, week by week and month by month. At Solcara, the order does not change: your history comes first, the labs are picked based on it, and a body composition baseline follows, all before a written plan with weekly coaching running beside it.

• The US Preventive Services Task Force recommends intensive, multicomponent behavioral programs for adults with a BMI of 30 or higher, and most programs it reviewed ran 1 to 2 years with 12 or more sessions in the first year.[1]
• National guidance suggests a first goal of losing 5% to 10% of your starting weight over about 6 months, and even 3% to 5% can lower triglycerides, blood sugar, and diabetes risk.[2][4]
• Blood sugar testing (an A1C, fasting glucose, or glucose tolerance test) is recommended for adults 35 to 70 who have overweight or obesity.[3]
• A waist over 35 inches for women or 40 inches for men raises heart disease and type 2 diabetes risk, which is why a tape measure belongs next to the scale.[4]
• Guidelines support weight loss medication alongside lifestyle care for a BMI of 30 or more, or 27 or more with a weight-related condition, when lifestyle changes alone have not been enough.[6][7]
• If a medication has not produced at least 5% weight loss after 12 weeks on its maximal dose, the AHA/ACC/TOS guideline asks clinicians to reassess its risks and benefits and consider stopping it.[2]

What happens at the first weight loss visit?

The first visit is mostly history. An intake can cover the shape of your weight over the years (when it started climbing, what you have tried, what worked for a while and then stopped), your eating pattern on an ordinary weekday, your sleep, your work hours, and what you actually want to change. For some people the goal is a number. For others it is blood sugar, knee pain, or keeping up with their kids.

A full medication list matters too. The Endocrine Society notes that many medicines prescribed for diabetes, depression, and other chronic conditions can promote weight gain or weight loss, and that choosing ones with favorable weight profiles, when possible, can help.[6] Bring every prescription, supplement, and over-the-counter product, with the date you started each.

The intake is also where safety screening begins, before any plan is written. Several questions shape what is safe for you later:

• Thyroid cancer history. Both semaglutide for weight loss (Wegovy) and tirzepatide (Zepbound) are contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2).[8][9]
• Pancreas and gallbladder history. Both labels list acute pancreatitis and acute gallbladder disease among their warnings.[8][9]
• Pregnancy plans. The Wegovy label says to stop the drug at least 2 months before a planned pregnancy because semaglutide stays in the body a long time.[8]
• Birth control. The Zepbound label advises people on birth control pills to switch to a non-oral method, or add a barrier method, for 4 weeks after starting and after each dose increase.[9]
• Upcoming procedures. Both labels ask patients to tell their clinicians about planned surgeries or procedures, because of reports of aspiration during anesthesia or deep sedation.[8][9]

None of this means you will be offered medication. It means the answers are on file if the conversation turns that way. If you have taken a GLP-1 drug before, bring the dose, the dates, the pharmacy that filled it, and what your weight did after you stopped, because that history shapes the next plan more than almost anything else.

Which lab tests come before a weight loss plan?

Labs exist to answer specific questions, not to fill a page. One lab question has a clear national recommendation behind it: blood sugar. The USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 who have overweight or obesity, using a fasting plasma glucose, an HbA1c, or an oral glucose tolerance test.[3] For adults whose first result is normal, it suggests rescreening every 3 years may be a reasonable approach.[3]

That result changes the plan. In the Diabetes Prevention Program, 3,234 adults with elevated blood sugar were randomly assigned to placebo, metformin, or a lifestyle program aiming for at least 7% weight loss and 150 minutes of activity a week.[5] Over an average of 2.8 years, the lifestyle program cut new cases of diabetes by 58% compared with placebo, and it worked better than metformin, which cut them by 31%.[5] The people in that trial had elevated blood sugar without diabetes, so if your labs show prediabetes, it is the most relevant trial to ask about at your visit.[5]

Beyond blood sugar, the panel is chosen to fit the history. The 2013 AHA/ACC/TOS guideline notes that a sustained 3% to 5% loss is likely to bring meaningful drops in triglycerides, blood glucose, and A1C, which is one reason a baseline matters.[2] Whether a thyroid test belongs on your panel depends on your symptoms and history, so raise it at the visit. Both GLP-1 drug labels call for monitoring kidney function in patients whose side effects could lead to volume depletion (fluid loss), so ask whether a baseline kidney test makes sense for you.[8][9] Our annual full panel labs page explains what a broad panel covers and where its limits are.

If you have type 2 diabetes, the Wegovy label calls for monitoring blood glucose before and during treatment, and both labels warn that combining these drugs with insulin or insulin-releasing pills can raise the risk of low blood sugar.[8][9] That is a reason to bring your diabetes medicines to the first visit, not a reason to skip the conversation.

Want to see what your own plan would look like? Call 843-981-0870. Ask about the intake, the labs chosen from your history, and the follow-up schedule.

Why measure your waist and body composition, not just your weight?

The scale tells you how much you weigh. It does not tell you where the weight sits or what it is made of, and both matter.

Start with the waist. The National Heart, Lung, and Blood Institute notes that carrying most of your fat around the waist rather than the hips raises the risk of heart disease and type 2 diabetes, and that risk rises with a waist over 35 inches for women or over 40 inches for men.[4] To measure it, stand, wrap the tape just above your hipbones, and read it just after you breathe out.[4] The AHA/ACC/TOS guideline advises measuring waist size at least once a year, or more often, in adults with overweight or obesity.[2]

Body composition adds a second layer. An InBody body composition analysis passes a small current through the body and uses equations to estimate body water, lean mass, and fat mass, so it is better at showing your direction over time than giving one exact number. We offer it at both our Mount Pleasant office and The Longevity Club in downtown Charleston, and Ashley reviews each scan alongside your history, labs, and goals. Our medical weight loss page describes the aim of repeating it during a plan: less fat at the same or better lean mass, measured the same way each time.

For that trend to mean anything, the conditions need to match each time: the same time of day, no workout, meal, or large drink beforehand, and, for people who have periods, the same point in the cycle. A baseline taken at the start of the program gives every later scan something to be compared against.

What goes into the plan itself?

Once the history, labs, and measurements are in, the plan gets written down. The AHA/ACC/TOS guideline is specific about what a comprehensive lifestyle program contains, and it names three parts that should all be included: a moderately reduced calorie diet, more physical activity, and behavioral strategies that help you stick with both.[2]

The eating plan. The guideline describes calorie targets that are usually 1,200 to 1,500 a day for women and 1,500 to 1,800 for men, adjusted for body weight and activity, or a daily deficit of 500 to 750 calories.[2] It also lists approaches that cut calories by limiting certain food groups instead of counting.[2] The guideline states that a variety of dietary approaches can produce weight loss in adults with overweight and obesity.[2] Which pattern fits your week is a question for the visit.

The activity plan. The usual starting prescription is aerobic activity such as brisk walking for at least 150 minutes a week, about 30 minutes on most days.[2] For keeping weight off over the long term, the guideline points higher, about 200 to 300 minutes a week.[2] Whether to add strength work is worth raising at your visit, and repeat body composition scans are one way to follow lean mass over time.

The behavior plan. The programs the USPSTF reviewed leaned on problem solving to identify barriers, self-monitoring of weight, peer support, and relapse prevention, often with tools like food diaries and pedometers.[1]

The target. A realistic first goal is 5% to 10% of your starting weight over about 6 months.[4] For someone at 220 pounds, that is 11 to 22 pounds. It sounds modest. The payoff is not: NHLBI notes that losing just 3% to 5% can lower triglycerides, blood sugar, and type 2 diabetes risk.[4] Our written plans name what each part is expected to do and how long it should take to show. For deeper work on the food side, our nutritional therapy service builds eating changes from your labs and routine.

How often will you be seen, and what happens at each follow-up?

On the question of how often you are seen, the guidelines are specific. The AHA/ACC/TOS guideline recommends high-intensity programs, meaning at least 14 sessions in 6 months, delivered in person by a trained interventionist, individually or in groups.[2] It found that this intensity typically produces more weight loss than lower-contact programs.[2] The USPSTF found much the same: most effective programs lasted 1 to 2 years, and the majority had 12 or more sessions in the first year.[1]

Our program pairs the plan with weekly coaching. As our medical weight loss page puts it, the behavior side is where the maintenance phase is won or lost, and no medication substitutes for it.

Here is how the stages usually line up over the first year and beyond. Exact timing is set to you, but these are the anchor points the guidelines describe.

Three questions are worth bringing to every follow-up. How do my numbers compare with my baseline, not just with last week? What got in the way since the last visit, and what changes because of it? Are there side effects or new symptoms to report, whether or not a medication is involved?

The maintenance phase gets its own recommendation. The guideline advises people who have lost weight to stay in a maintenance program for at least a year, with monthly or more frequent contact, 200 to 300 minutes a week of activity, and weighing themselves weekly or more often.[2] It also states plainly that some regain is expected on average after initial weight loss, and that continued maintenance support reduces it compared with minimal follow-up.[2] Knowing that in advance makes it something to plan for.

Where does weight loss medication fit in?

Medication is a tool for some patients at some points, and the guidelines are fairly clear about who and when. The American Gastroenterological Association's 2022 guideline strongly recommends adding medication to lifestyle care for adults with a BMI of 30 or higher, or 27 or higher with weight-related complications, who have had an inadequate response to lifestyle changes alone.[7] The Endocrine Society frames these drugs the same way, as useful adjuncts for people who have not succeeded with diet and exercise alone.[6]

The AGA panel suggested semaglutide 2.4 mg, liraglutide 3.0 mg, phentermine-topiramate ER, and naltrexone-bupropion ER based on moderate certainty evidence, and suggested against orlistat.[7] One limit is worth knowing: tirzepatide was not on the list of drugs the AGA panel reviewed for that guideline.[7] Its use for chronic weight management rests on its FDA label, which approves Zepbound for adults with obesity, or with overweight plus at least one weight-related condition, alongside a reduced-calorie diet and more activity.[9]

Starting low and going slow. These drugs are not started at full strength. The Wegovy injection label starts at 0.25 mg once a week for 4 weeks, then steps up every 4 weeks to reduce stomach and bowel side effects, and suggests delaying the next step by 4 weeks if a dose is not tolerated.[8] The Zepbound label starts at 2.5 mg once weekly for 4 weeks, rising in 2.5 mg steps after at least 4 weeks.[9] Nausea, diarrhea, vomiting, and constipation are among the most common side effects listed for both.[8][9] Because the Wegovy label ties each step up to whether the current dose is tolerated, each step is a natural point to check in.[8]

The 12-week checkpoint. The AHA/ACC/TOS guideline says that if a patient taking a weight loss medication has not lost at least 5% of initial body weight after 12 weeks on a maximal dose, the clinician should reassess the drug's risk-to-benefit ratio and consider stopping it.[2] That guideline predates the newest drugs, and the Wegovy injection schedule alone takes 16 weeks to reach its maintenance step, so read the 12 weeks as starting at the maximal dose, as the guideline words it, not at the first injection.[8] For how a specific drug is started, adjusted, or stopped for safety reasons, its current FDA label is the document to read.[8][9]

What happens if you stop. The STEP 4 trial gave 803 adults semaglutide for 20 weeks, during which they lost an average of 10.6%, then randomly switched about a third to placebo.[10] Over the next 48 weeks, those who stayed on semaglutide lost another 7.9%, while those switched to placebo gained back 6.9%.[10] Both groups kept their lifestyle program.[10] In that trial, the effect depended on staying on the drug, so a plan that includes one needs an honest conversation about the long run, including cost, which our post on GLP-1 weight loss costs in Charleston covers in detail.

At Solcara, medication is one tool and it is not required, and none is started without the assessment, because the point of the assessment is to find out whether it is the right tool at all. If a prescription does become part of your plan, ask exactly which product it is, whether it is the FDA-approved drug or a compounded preparation, and which pharmacy dispenses it. Our medical weight loss page lays out the trial results and the FDA's position on compounded versions.

For women in perimenopause or menopause, hormones can enter this conversation too. Our post on hormone therapy alongside tirzepatide or semaglutide in menopause looks at how the two are considered together.

Ashley Harwyn, PA-C PA-C, ABAAHP · Founder, Solcara Health Online

Tap a question to ask

About the author

Ashley Harwyn, PA-C, ABAAHP

Founder, Solcara Health · Diplomate, American Board of Anti-Aging Health Practitioners (ABAAHP)

Ashley has practiced medicine for more than fifteen years. Her path into it began at home, with a family member born with a congenital heart defect and a childhood spent watching how much the quality of a clinician's attention could change the shape of a life. She has since practiced across a range of settings, including medical mission work in Uganda, before founding Solcara to build the kind of practice she kept wishing existed, one that treats patients as whole people and tells them the truth about what the evidence does and does not support.

Full bio →